Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebru Karcı

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|July 12, 2025
Radiologic Predictors of Disease Recurrence in Nasopharyngeal Carcinoma: A Retrospective Evaluation of MRI and <sup>18</sup>F-FDG-PET/CT ParametersBanu Karaalioğlu, Tansel Çakır, Ömer Yazıcı, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 21, 2016
Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic LeukemiaAli Alkan, Tuğçe Kütük, Ebru Karcı, et al.
Biomolecules & Biomedicine|April 9, 2026
Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapyEbru Karcı, Ferhat Ozden, Elif Kuzucular, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAli Alkan, Arzu Yaşar, Ebru Karcı, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2017
Vaccination in oncology practice and predictorsAli Alkan, Ebru Karcı, Arzu Yaşar, et al.
Journal of Cancer Research and Therapeutics|July 18, 2024
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric CancerAli Alkan, Dilşa Mızrak, Arzu Yaşar, et al.
Cancer Investigation|March 24, 2017
Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group StudyCemil Bilir, İbrahim Yıldız, Ahmet Bilici, et al.
European Journal of Cancer Care|September 1, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|July 12, 2025
Radiologic Predictors of Disease Recurrence in Nasopharyngeal Carcinoma: A Retrospective Evaluation of MRI and <sup>18</sup>F-FDG-PET/CT ParametersBanu Karaalioğlu, Tansel Çakır, Ömer Yazıcı, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|April 21, 2016
Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic LeukemiaAli Alkan, Tuğçe Kütük, Ebru Karcı, et al.
Biomolecules & Biomedicine|April 9, 2026
Claudin 18.2, IDH1, and neutrophil-to-lymphocyte ratio as prognostic biomarkers in unresectable pancreatic ductal adenocarcinoma receiving first-line chemotherapyEbru Karcı, Ferhat Ozden, Elif Kuzucular, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAli Alkan, Arzu Yaşar, Ebru Karcı, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2017
Vaccination in oncology practice and predictorsAli Alkan, Ebru Karcı, Arzu Yaşar, et al.
Journal of Cancer Research and Therapeutics|July 18, 2024
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric CancerAli Alkan, Dilşa Mızrak, Arzu Yaşar, et al.
Cancer Investigation|March 24, 2017
Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group StudyCemil Bilir, İbrahim Yıldız, Ahmet Bilici, et al.
European Journal of Cancer Care|September 1, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, et al.
Pageof 1